Cite Filings / XERS
Feed Companies Filings Check
Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Filings Financials Insiders Search text
All 346 Financials 79 Shareholder Meetings 5 Executive Compensation 68 Insider Trading 178 Beneficial Ownership Interest 18 Business Combinations 62 Public Offerings 19 Mutual Funds and ETFs 5 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. 10-K Report Annual Report 2022-03-11
  3. 8-K Event ● Material agreement · Results of operations · New debt or obligation · Other events 2022-03-10
  4. 8-K Event Other events 2022-01-28
  5. 8-K Event ● Results of operations 2022-01-18
  6. 8-K Event ● Material agreement · Unregistered share sale · Other events 2022-01-03
  7. 8-K Event ● Results of operations 2021-11-10
  8. 8-K Event Other events 2021-10-08
  9. 8-K Event ● Executive or director change 2021-10-05

Page 4 of 4 · 68 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…